Table 4.
Univariate and multivariable analysis for OS incorporating values of Tim-3 and sIL2-Rα dichotomized in two groups.
OS Univariate | OS Multivariate*** | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Tim3 over 950 pg/ml |
4.699 | 1.652–13.080 | 0.003 | 6.214 | 1.939–19.910 | 0.002 |
REC IL-2 over 8,100 pg/ml |
2.762 | 1.530–4.988 | 0.0007 | 2.644 | 1.308–5.347 | 0.006 |
Age | 1.034 | 1.007–1.062 | 0.01 | 1.001 | 0.974–1.028 | 0.95 |
Source: Marrow vs. PBSC |
2.053 | 1.142–3.691 | 0.01 | 2.328 | 1.082–5.007 | 0.03 |
Diagnosis: MDS/AA/MPN |
0.223 | 0.054–0.920 | 0.03 | 0.097 | 0.013–0.726 | 0.02 |
Donor type: MUD-HAPLO vs. HLA-ID SIBLING |
1.450 | 0.814–2.585 | 0.20 | 1.100 | 0.484–2.502 | 0.82 |
GVHD prophylaxis: other than CSA + MTX + ATG vs. CSA + MTX + ATG |
1.794 | 1.011–3.184 | 0.04 | 2.313 | 1.030–5.192 | 0.04 |
Conditioning regimen FMA vs. RIC |
1.038 | 0.503–2.139 | 0.92 |
Studied in the set of 75 patients in which both data on TIM-3 and REC IL-2 were available.